Recent development of silica nanoparticles as delivery vectors for cancer imaging and therapy

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 10, Issue 2, 2014, Pages 297-312

  Wu, Xu ^a   Wu, Min ^b   Zhao, Julia Xiaojun ^a  

^a UNIVERSITY OF NORTH DAKOTA   (United States)

^b UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Multifunctional; Silica nanoparticles; Tumor diagnosis; Tumor therapy

Indexed keywords

MULTIFUNCTIONAL; SILICA NANOPARTICLES; TUMOR DIAGNOSIS; TUMOR THERAPY;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOCOMPATIBLE MATERIALS; BIOLOGICAL MARKERS; DRUG DELIVERY SYSTEMS; GENETIC THERAPY; HELA CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE; NANOMEDICINE; NANOPARTICLES; NEOPLASMS; PARTICLE SIZE; PEPTIDES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROGNOSIS; QUANTUM DOTS; RNA, SMALL INTERFERING; SILICON DIOXIDE; SURFACE PROPERTIES;

EID: 84895068605     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2013.08.008     Document Type: Review

References (118)

1. Zhao Y., Trewyn B.G., Slowing I.I., Lin V.S.Y. Mesoporous silica nanoparticle-based double drug delivery system for glucose-responsive controlled release of insulin and cyclic AMP. J Am Chem Soc 2009, 131:8398-8400.
2. Patil Y.B., Swaminathan S.K., Sadhukha T., Ma L., Panyam J. The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance. Biomaterials 2010, 31:358-365.
3. Fang W., Yang J., Gong J., Zheng N. Photo- and pH-triggered release of anticancer drugs from mesoporous silica-coated Pd at Ag nanoparticles. Adv Funct Mater 2012, 22:842-848.
4. Klichko Y., Liong M., Choi E., Angelos S., Nel A.E., Stoddart J.F., et al. Mesostructured silica for optical functionality, nanomachines, and drug delivery. J Am Ceram Socm 2009, 92:S2-S10.
5. Kim J.H., Noh Y.-W., Heo M.B., Cho M.Y., Lim Y.T. Multifunctional hybrid nanoconjugates for efficient in vivo delivery of immunomodulating oligonucleotides and enhanced antitumor immunity. Angew Chem Int Ed 2012, 51:9670-9673.
6. Bagalkot V., Gao X. siRNA-aptamer chimeras on nanoparticles: preserving targeting functionality for effective gene silencing. ACS Nano 2011, 5:8131-8139.
7. Sardesai N.P., Barron J.C., Rusling J.F. Carbon nanotube microwell array for sensitive electrochemiluminescent detection of cancer biomarker proteins. Anal Chem 2011, 83:6698-6703.
8. Chen T., Shukoor M.I., Wang R., Zhao Z., Yuan Q., Bamrungsap S., et al. Smart multifunctional nanostructure for targeted cancer chemotherapy and magnetic resonance imaging. ACS Nano 2011, 5:7866-7873.
9. Gao Y., Yang C., Liu X., Ma R., Kong D., Shi L. A multifunctional nanocarrier based on nanogated mesoporous silica for enhanced tumor-specific uptake and intracellular delivery. Macromol Biosci 2012, 12:251-259.
10. Unezaki S., Maruyama K., Hosoda J.-I., Nagae I., Koyanagi Y., Nakata M., et al. Direct measurement of the extravasation of polyethyleneglycol-coated liposomes into solid tumor tissue by in vivo fluorescence microscopy. Int J Pharm 1996, 144:11-17.
11. Xia T., Kovochich M., Liong M., Meng H., Kabehie S., George S., et al. Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. ACS Nano 2009, 3:3273-3286.
12. Wu X., He X., Wang K., Xie C., Zhou B., Qing Z. Ultrasmall near-infrared gold nanoclusters for tumor fluorescence imaging in vivo. Nanoscale 2010, 2:2244-2249.
13. Gordon S., Teichmann E., Young K., Finnie K., Rades T., Hook S. In vitro and in vivo investigation of thermosensitive chitosan hydrogels containing silica nanoparticles for vaccine delivery. Eur J Pharm Sci 2010, 41:360-368.
14. Gao X., Cui Y., Levenson R.M., Chung L.W., Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004, 22:969-976.
15. Cheng Y.C., Samia A., Meyers J.D., Panagopoulos I., Fei B., Burda C. Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. J Am Chem Soc 2008, 130:10643-10647.
16. Michalet X., Pinaud F.F., Bentolila L.A., Tsay J.M., Doose S., Li J.J., et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005, 307:538-544.
17. Moon H.K., Lee S.H., Choi H.C. In vivo near-infrared mediated tumor destruction by photothermal effect of carbon nanotubes. ACS Nano 2009, 3:3707-3713.
18. Lewin M., Carlesso N., Tung C.H., Tang X.W., Cory D., Scadden D.T., et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 2000, 18:410-414.
19. Cao Z., Tong R., Mishra A., Xu W., Wong G.C.L., Cheng J., et al. Reversible cell-specific drug delivery with aptamer-functionalized liposomes. Angew Chem Int Ed 2009, 48:6494-6498.
20. Wu S.H., Hung Y., Mou C.Y. Mesoporous silica nanoparticles as nanocarriers. Chem Commun 2011, 47:9972-9985.
21. Sumer B., Gao J. Theranostic nanomedicine for cancer. Nanomedicine 2008, 3:137-140.
22. Louie A. Multimodality imaging probes: design and challenges. Chem Rev 2010, 110:3146-3195.
23. Rosenholm J.M., Sahlgren C., Linden M. Multifunctional mesoporous silica nanoparticles for combined therapeutic, diagnostic and targeted action in cancer treatment. Curr Drug Targets 2011, 12:1166-1186.
24. Trewyn B.G., Giri S., Slowing I.I., Lin V.S.Y. Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems. Chem Commun 2007, 3236-3245.
25. Slowing I.I., Vivero-Escoto J.L., Wu C.-W., Lin V.S.Y. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 2008, 60:1278-1288.
26. Bae S.W., Tan W., Hong J.I. Fluorescent dye-doped silica nanoparticles: new tools for bioapplications. Chem Commun 2012, 48:2270-2282.
27. Li Z., Barnes J.C., Bosoy A., Stoddart J.F., Zink J.I. Mesoporous silica nanoparticles in biomedical applications. Chem Soc Rev 2012, 41:2590-2605.
28. Gao Y., Chen Y., Ji X., He X., Yin Q., Zhang Z., et al. Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles. ACS Nano 2011, 5:9788-9798.
29. Singh N., Karambelkar A., Gu L., Lin K., Miller J.S., Chen C.S., et al. Bioresponsive mesoporous silica nanoparticles for triggered drug release. J Am Chem Soc 2011, 133:19582-19585.
30. He X., Wu X., Wang K., Shi B., Hai L. Methylene blue-encapsulated phosphonate-terminated silica nanoparticles for simultaneous in vivo imaging and photodynamic therapy. Biomaterials 2009, 30:5601-5609.
31. Herr J.K., Smith J.E., Medley C.D., Shangguan D., Tan W. Aptamer-conjugated nanoparticles for selective collection and detection of cancer cells. Anal Chem 2006, 78:2918-2924.
32. Lu J., Li Z., Zink J.I., Tamanoi F. In vivo tumor suppression efficacy of mesoporous silica nanoparticles-based drug-delivery system: enhanced efficacy by folate modification. Nanomedicine: NBM 2012, 8:212-220.
33. He X., Nie H., Wang K., Tan W., Wu X., Zhang P. In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles. Anal Chem 2008, 80:9597-9603.
34. Liu T., Li L., Teng X., Huang X., Liu H., Chen D., et al. Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice. Biomaterials 2011, 32:1657-1668.
35. Lu F., Wu S.-H., Hung Y., Mou C.-Y. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small 2009, 5:1408-1413.
36. Tang F., Li L., Chen D. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Adv Mater 2012, 24:1504-1534.
37. Bagwe R.P., Yang C., Hilliard L.R., Tan W. Optimization of dye-doped silica nanoparticles prepared using a reverse microemulsion method. Langmuir 2004, 20:8336-8342.
38. Jin Y., Lohstreter S., Pierce D.T., Parisien J., Wu M., Hall C., et al. Silica nanoparticles with continuously tunable sizes: synthesis and size effects on cellular contrast imaging. Chem Mater 2008, 20:4411-4419.
39. Pan L., He Q., Liu J., Chen Y., Ma M., Zhang L., et al. Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles. J Am Chem Soc 2012, 134:5722-5725.
40. Rossi L.M., Shi L., Quina F.H., Rosenzweig Z. Stober synthesis of monodispersed luminescent silica nanoparticles for bioanalytical assays. Langmuir 2005, 21:4277-4280.
41. Napierska D., Thomassen L.C.J., Rabolli V., Lison D., Gonzalez L., Kirsch-Volders M., et al. Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. Small 2009, 5:846-853.
42. Torchilin V. Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev 2011, 63:131-135.
43. Li L., Tang F., Liu H., Liu T., Hao N., Chen D., et al. In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy. ACS Nano 2010, 4:6874-6882.
44. Wilson N.S., Yang B., Yang A., Loeser S., Marsters S., Lawrence D., et al. An Fcgamma receptor-dependent mechanism drives antibody-mediated target-receptor signaling in cancer cells. Cancer Cell 2011, 19:101-113.
45. Smith B.R., Cheng Z., De A., Koh A.L., Sinclair R., Gambhir S.S. Real-time intravital imaging of RGD-quantum dot binding to luminal endothelium in mouse tumor neovasculature. Nano Lett 2008, 8:2599-2606.
46. Ferris D.P., Lu J., Gothard C., Yanes R., Thomas C.R., Olsen J.C., et al. Synthesis of biomolecule-modified mesoporous silica nanoparticles for targeted hydrophobic drug delivery to cancer cells. Small 2011, 7:1816-1826.
47. Porta F., Lamers G.E.M., Morrhayim J., Chatzopoulou A., Schaaf M., den Dulk H., et al. Folic acid-modified mesoporous silica nanoparticles for cellular and nuclear targeted drug delivery. Adv Healthcare Mater 2012, 2:281-286.
48. Dhar S., Kolishetti N., Lippard S.J., Farokhzad O.C. Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo. Proc Natl Acad Sci 2011, 108:1850-1855.
49. Wang L., Zhao W., Tan W. Bioconjugated silica nanoparticles: development and applications. Nano Res 2008, 1:99-115.
50. Calfon M.A., Rosenthal A., Mallas G., Mauskapf A., Nudelman R.N., Ntziachristos V., et al. In vivo near infrared fluorescence (NIRF) intravascular molecular imaging of inflammatory plaque, a multimodal approach to imaging of atherosclerosis. J Vis Exp 2011, 54:e2257.
51. Condeelis J., Weissleder R. In vivo imaging in cancer. Cold Spring Harb Perspect Biol 2010, 2:a003848.
52. Oleinikov V.A. Semiconductor fluorescent nanocrystals (quantum dots) in biological biochips. Bioorg Khim 2011, 37:171-189.
53. Zhao X., Tapec-Dytioco R., Tan W. Ultrasensitive DNA detection using highly fluorescent bioconjugated nanoparticles. J Am Chem Soc 2003, 125:11474-11475.
54. Santra S., Zhang P., Wang K., Tapec R., Tan W. Conjugation of biomolecules with luminophore-doped silica nanoparticles for photostable biomarkers. Anal Chem 2001, 73:4988-4993.
55. Veeranarayanan S., Cheruvathoor Poulose A., Mohamed S., Aravind A., Nagaoka Y., Yoshida Y., et al. FITC labeled silica nanoparticles as efficient cell tags: uptake and photostability study in endothelial cells. J Fluoresc 2012, 22:537-548.
56. Zhu C.-L., Lu C.-H., Song X.-Y., Yang H.-H., Wang X.-R. Bioresponsive controlled release using mesoporous silica nanoparticles capped with aptamer-based molecular gate. J Am Chem Soc 2011, 133:1278-1281.
57. He X., Zhao Y., He D., Wang K., Xu F., Tang J. ATP-responsive controlled release system using aptamer-functionalized mesoporous silica nanoparticles. Langmuir 2012, 28:12909-12915.
58. Tsai C.-P., Chen C.-Y., Hung Y., Chang F.-H., Mou C.-Y. Monoclonal antibody-functionalized mesoporous silica nanoparticles (MSN) for selective targeting breast cancer cells. J Mater Chem 2009, 19:5737-5743.
59. Kumar R., Roy I., Ohulchanskyy T.Y., Goswami L.N., Bonoiu A.C., Bergey E.J., et al. Covalently dye-linked, surface-controlled, and bioconjugated organically modified silica nanoparticles as targeted probes for optical imaging. ACS Nano 2008, 2:449-456.
60. Wu P., He X., Wang K., Tan W., Ma D., Yang W., et al. Imaging breast cancer cells and tissues using peptide-labeled fluorescent silica nanoparticles. J Nanosci Nanotechnol 2008, 8:2483-2487.
61. Wang X., Yao S., Ahn H.Y., Zhang Y., Bondar M.V., Torres J.A., et al. Folate receptor targeting silica nanoparticle probe for two-photon fluorescence bioimaging. Biomed Opt Expr 2010, 1:453-462.
62. Lebret V., Raehm L., Durand J.O., Smaihi M., Werts M.H., Blanchard-Desce M., et al. Folic acid-targeted mesoporous silica nanoparticles for two-photon fluorescence. J Biomed Nanotechnol 2010, 6:176-180.
63. Iliuk A.B., Hu L., Tao W.A. Aptamer in bioanalytical applications. Anal Chem 2011, 83:4440-4452.
64. Medley C.D., Bamrungsap S., Tan W., Smith J.E. Aptamer-conjugated nanoparticles for cancer cell detection. Anal Chem 2011, 83:727-734.
65. Lu J., Liong M., Li Z., Zink J.I., Tamanoi F. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small 2010, 6:1794-1805.
66. Qian J., Wang D., Cai F., Zhan Q., Wang Y., He S. Photosensitizer encapsulated organically modified silica nanoparticles for direct two-photon photodynamic therapy and in vivo functional imaging. Biomaterials 2012, 33:4851-4860.
67. Matsumura Y., Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986, 46:6387-6392.
68. Shukla R., Chanda N., Zambre A., Upendran A., Katti K., Kulkarni R.R., et al. Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCg) show efficacy in treating prostate cancer. Proc Natl Acad Sci 2012, 109:12426-12431.
69. Huang X., Luo Y., Li Z., Li B., Zhang H., Li L., et al. Biolabeling hematopoietic system cells using near-infrared fluorescent gold nanoclusters. J Phys Chem C 2011, 115:16753-16763.
70. 2S quantum dots in the second near-infrared region. Angew Chem Int Ed 2012, 124:9956-9959.
71. Xiong L.Q., Chen Z.G., Yu M.X., Li F.Y., Liu C., Huang C.H. Synthesis, characterization, and in vivo targeted imaging of amine-functionalized rare-earth up-converting nanophosphors. Biomaterials 2009, 30:5592-5600.
72. Xiong L., Chen Z., Tian Q., Cao T., Xu C., Li F. High contrast upconversion luminescence targeted imaging in vivo using peptide-labeled nanophosphors. Anal Chem 2009, 81:8687-8694.
73. Jun B.-H., Hwang D.W., Jung H.S., Jang J., Kim H., Kang H., et al. Ultrasensitive, biocompatible, quantum-dot-embedded silica nanoparticles for bioimaging. Adv Funct Mater 2012, 22:1843-1849.
74. Taylor K.M.L., Kim J.S., Rieter W.J., An H., Lin W., Lin W. Mesoporous silica nanospheres as highly efficient MRI contrast agents. J Am Chem Soc 2008, 130:2154-2155.
75. Kim J.S., Rieter W.J., Taylor K.M.L., An H., Lin W., Lin W. Self-assembled hybrid nanoparticles for cancer-specific multimodal imaging. J Am Chem Soc 2007, 129:8962-8963.
76. Koole R., van Schooneveld M.M., Hilhorst J., Castermans K., Cormode D.P., Strijkers G.J., et al. Paramagnetic lipid-coated silica nanoparticles with a fluorescent quantum dot core: a new contrast agent platform for multimodality imaging. Bioconjug Chem 2008, 19:2471-2479.
77. Kim J., Kim H.S., Lee N., Kim T., Kim H., Yu T., et al. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew Chem Int Ed 2008, 47:8438-8441.
78. Liong M., Lu J., Kovochich M., Xia T., Ruehm S.G., Nel A.E., et al. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2008, 2:889-896.
79. Lee J.E., Lee N., Kim H., Kim J., Choi S.H., Kim J.H., et al. Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery. J Am Chem Soc 2009, 132:552-557.
80. Lu C.W., Hung Y., Hsiao J.K., Yao M., Chung T.H., Lin Y.S., et al. Bifunctional magnetic silica nanoparticles for highly efficient human stem cell labeling. Nano Lett 2007, 7:149-154.
81. Liu H.M., Wu S.H., Lu C.W., Yao M., Hsiao J.K., Hung Y., et al. Mesoporous silica nanoparticles improve magnetic labeling efficiency in human stem cells. Small 2008, 4:619-626.
82. Lu J., Liong M., Zink J.I., Tamanoi F. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small 2007, 3:1341-1346.
83. Tsai C.H., Vivero-Escoto J.L., Slowing I.I., Fang I.J., Trewyn B.G., Lin V.S. Surfactant-assisted controlled release of hydrophobic drugs using anionic surfactant templated mesoporous silica nanoparticles. Biomaterials 2011, 32:6234-6244.
84. He X., Hai L., Su J., Wang K., Wu X. One-pot synthesis of sustained-released doxorubicin silica nanoparticles for aptamer targeted delivery to tumor cells. Nanoscale 2011, 3:2936-2942.
85. Lai C.Y., Trewyn B.G., Jeftinija D.M., Jeftinija K., Xu S., Jeftinija S., et al. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. J Am Chem Soc 2003, 125:4451-4459.
86. Chen C., Geng J., Pu F., Yang X., Ren J., Qu X. Polyvalent nucleic acid/mesoporous silica nanoparticle conjugates: dual stimuli-responsive vehicles for intracellular drug delivery. Angew Chem Int Ed 2011, 50:882-886.
87. Meng H., Xue M., Xia T., Zhao Y.-L., Tamanoi F., Stoddart J.F., et al. Autonomous in vitro anticancer drug release from mesoporous silica nanoparticles by pH-sensitive nanovalves. J Am Chem Soc 2010, 132:12690-12697.
88. Liu R., Zhang Y., Zhao X., Agarwal A., Mueller L.J., Feng P. pH-responsive nanogated ensemble based on gold-capped mesoporous silica through an acid-labile acetal linker. J Am Chem Soc 2010, 132:1500-1501.
89. Roy I., Ohulchanskyy T.Y., Pudavar H.E., Bergey E.J., Oseroff A.R., Morgan J., et al. Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. J Am Chem Soc 2003, 125:7860-7865.
90. Kim S., Ohulchanskyy T.Y., Pudavar H.E., Pandey R.K., Prasad P.N. Organically modified silica nanoparticles co-encapsulating photosensitizing drug and aggregation-enhanced two-photon absorbing fluorescent dye aggregates for two-photon photodynamic therapy. J Am Chem Soc 2007, 129:2669-2675.
91. Ohulchanskyy T.Y., Roy I., Goswami L.N., Chen Y., Bergey E.J., Pandey R.K., et al. Organically modified silica nanoparticles with covalently incorporated photosensitizer for photodynamic therapy of cancer. Nano Lett 2007, 7:2835-2842.
92. Zhang P., Steelant W., Kumar M., Scholfield M. Versatile photosensitizers for photodynamic therapy at infrared excitation. J Am Chem Soc 2007, 129:4526-4527.
93. Gary-Bobo M., Hocine O., Brevet D., Maynadier M., Raehm L., Richeter S., et al. Cancer therapy improvement with mesoporous silica nanoparticles combining targeting, drug delivery and PDT. Int J Pharm 2012, 423:509-515.
94. Zhu J., Wang H., Liao L., Zhao L., Zhou L., Yu M., et al. Small mesoporous silica nanoparticles as carriers for enhanced photodynamic therapy. Chem Asian J 2011, 6:2332-2338.
95. He X.X., Wang K., Tan W., Liu B., Lin X., He C., et al. Bioconjugated nanoparticles for DNA protection from cleavage. J Am Chem Soc 2003, 125:7168-7169.
96. Peng J., He X., Wang K., Tan W., Li H., Xing X., et al. An antisense oligonucleotide carrier based on amino silica nanoparticles for antisense inhibition of cancer cells. Nanomedicine: NBM 2006, 2:113-120.
97. Meng H., Liong M., Xia T., Li Z., Ji Z., Zink J.I., et al. Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line. ACS Nano 2010, 4:4539-4550.
98. Chen A.M., Zhang M., Wei D., Stueber D., Taratula O., Minko T., et al. Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells. Small 2009, 5:2673-2677.
99. Mai W.X., Meng H. Mesoporous silica nanoparticles: a multifunctional nano therapeutic system. Integr Biol 2013, 5:19-28.
100. Zhang Q., Liu F., Nguyen K.T., Ma X., Wang X., Xing B., et al. Multifunctional mesoporous silica nanoparticles for cancer-targeted and controlled drug delivery. Adv Funct Mater 2012, 22:5144-5156.
101. Joshi R., Feldmann V., Koestner W., Detje C., Gottschalk S., Mayer H.A., et al. Multifunctional silica nanoparticles for optical and magnetic resonance imaging. Biol Chem 2013, 394:125-135.
102. 4/TaO(x) core/shell nanoparticles for simultaneous magnetic resonance imaging and X-ray computed tomography. J Am Chem Soc 2012, 134:10309-10312.
103. Huang X., Zhang F., Wang H., Niu G., Choi K.Y., Swierczewska M., et al. Mesenchymal stem cell-based cell engineering with multifunctional mesoporous silica nanoparticles for tumor delivery. Biomaterials 2013, 34:1772-1780.
104. Meng H., Mai W.X., Zhang H., Xue M., Xia T., Lin S., et al. Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo. ACS Nano 2013, 7:994-1005.
105. Rosenholm J.M., Sahlgren C., Linden M. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles-opportunities & challenges. Nanoscale 2010, 2:1870-1883.
106. Benachour H., Seve A., Bastogne T., Frochot C., Vanderesse R., Jasniewski J., et al. Multifunctional peptide-conjugated hybrid silica nanoparticles for photodynamic therapy and MRI. Theranostics 2012, 2:889-904.
107. Mignot A., Truillet C., Lux F., Sancey L., Louis C., Denat F., et al. A top-down synthesis route to ultrasmall multifunctional Gd-based silica nanoparticles for theranostic applications. Chem Asian J 2013, 19:6122-6136.
108. Chen N.-T., Cheng S.-H., Souris J.S., Chen C.-T., Mou C.-Y., Lo L.-W. Theranostic applications of mesoporous silica nanoparticles and their organic/inorganic hybrids. J Mater Chem B 2013, 1:3128-3135.
109. Wang X., Chen H., Zheng Y., Ma M., Chen Y., Zhang K., et al. Au-nanoparticle coated mesoporous silica nanocapsule-based multifunctional platform for ultrasound mediated imaging, cytoclasis and tumor ablation. Biomaterials 2013, 34:2057-2068.
110. Chen Y., Chen H., Zeng D., Tian Y., Chen F., Feng J., et al. Core/shell structured hollow mesoporous nanocapsules: a potential platform for simultaneous cell imaging and anticancer drug delivery. ACS Nano 2010, 4:6001-6013.
111. Huang P., Bao L., Zhang C., Lin J., Luo T., Yang D., et al. Folic acid-conjugated silica-modified gold nanorods for X-ray/CT imaging-guided dual-mode radiation and photo-thermal therapy. Biomaterials 2011, 32:9796-9809.
112. Huschka R., Zuloaga J., Knight M.W., Brown L.V., Nordlander P., Halas N.J. Light-induced release of DNA from gold nanoparticles: nanoshells and nanorods. J Am Chem Soc 2011, 133:12247-12255.
113. Zhang Z., Wang L., Wang J., Jiang X., Li X., Hu Z., et al. Mesoporous silica-coated gold nanorods as a light-mediated multifunctional theranostic platform for cancer treatment. Adv Mater 2012, 24:1418-1423.
114. Zhao Z., Han Y., Lin C., Hu D., Wang F., Chen X., et al. Multifunctional core-shell upconverting nanoparticles for imaging and photodynamic therapy of liver cancer cells. Chem Asian J 2012, 7:830-837.
115. Bardhan R., Lal S., Joshi A., Halas N.J. Theranostic nanoshells: from probe design to imaging and treatment of cancer. Acc Chem Res 2011, 44:936-946.
116. He Q., Zhang Z., Gao F., Li Y., Shi J. In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation. Small 2011, 7:271-280.
117. Tao Z., Toms B.B., Goodisman J., Asefa T. Mesoporosity and functional group dependent endocytosis and cytotoxicity of silica nanomaterials. Chem Res Toxicol 2009, 22:1869-1880.
118. He Q., Zhang J., Shi J., Zhu Z., Zhang L., Bu W., et al. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. Biomaterials 2010, 31:1085-1092.